Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 25% in morning trade. The trial results set the ...
Ringside’s phase 3 findings reveal the potential varegacestat has to deliver “best-in-class results in a convenient, ...
Merck Animal Health announces the availability of Circumvent CL, a ready to use vaccine developed to protect pigs three weeks of age and older from disease caused by Porcine Circovirus Types 2a and 2d ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...
GlobalCapital presents the nominations for its Syndicated Loan, Leveraged Finance and Private Debt Awards 2025. The Awards, ...
One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...
By Annette Bakker The tragedy of rare disease is not only measured in lives lost—it’s also measured in lives that could have ...
Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's and related diseases that is potentially worth over $3 ...
FRANKFURT (Reuters) -Germany’s Merck KGaA on Thursday agreed to use Boston-based Valo Health’s drug research services in a collaboration focused on Parkinson’s and related diseases that is potentially ...
STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that long-term efficacy and safety data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback